Cardiology Research Fellow | Imperial College London
London, England
Joined July 2022
- Tweets39
- Following112
- Followers148
- Likes165
Florentina Simader retweeted
Check out @EuroInterventio Turning Point episode 2 with @rallamee
🎧 eurointervention.pcronline.c…
@DFCapodanno @PCRonline
@ShrillaB @mirvatalasnag @WomenAs1 @rajkumar_chris @ProfDFrancis @MikeFoley89 @fiyyazAJ @ShaynaChotai @FloSimader @mshunshin @NievesGonzalo1 @nickaram @Hragy
Episode 2 of Turning Point is here!
Host @aayshacader speaks with @rallamee about her path from clinician to pioneering researcher.
From early grant struggles to leading the ORBITA trial, discover how resilience, courage & teamwork shaped her career.
Florentina Simader retweeted
Michael foley presenting orbita 2 analysis showing that ffr and ifr predict angina benefit from pci.
Absolute values matter more than dichotimous cutoff. I would personally like to see how microvascular function fits into this @rallamee @mirvatalasnag @OKhaliqueMD @Hragy @ColletCarlos @DrPeterOKane @gap0161prevent @TTelila @alaide_chief #TCT2024
🔥🔥🔥
It was such a pleasure to join @rallamee to talk all things ESC 2024
Thank you so much @TheLancet #chloewilson
open.spotify.com/episode/5Ae…
Florentina Simader retweeted
Watch This Week's Episode of OPCI Journal Club: “ORBITA-STAR Trial and the ORBITA II Symptoms Analysis” presented by @rallamee @rajkumar_chris and @FloSimader. Joined by panelists @djc795 @JWMoses @ESHLOF and Dr. Lawrence Garcia. opci.live/journal-club/ #cardiotwitter
Florentina Simader retweeted
Just in case you thought the ORBITA team had gone on summer vacation… The first ORBITA-MOON case was completed yesterday. Another n-of-1 trial that might have some interesting results. Well done @ShaynaChotai on achieving the first of many big milestones during your PhD!
Florentina Simader retweeted
#cvCAD patients who have angina are more likely to achieve symptom relief from #PCI, according to an analysis of the ORBITA-2 trial in #JACC. bit.ly/3V3K3LW @TCTMD @TCTMD_Caitlin
Merci Paris and #euroPCR for an incredible week and experience with the best Team and colleagues✨ @rallamee @JACCJournals @PCRonline
Florentina Simader retweeted
ORBITA-2: Angina Phenotype Strongly Predicts PCI Response @rallamee @FloSimader
tctmd.com/news/orbita-2-angi…
So grateful and proud to have such an incredible mentor and role model @rallamee ✨
As always my team make me very proud. Today we launched our newest ORBITA fellow @FloSimader who did the most fabulous job of explaining how symptoms predict outcomes from ORBITA-2 @JACCJournals @mshunshin
Florentina Simader retweeted
.@FloSimader on #ORBITA-2 at #EuroPCR:
📌Poor correlation between symptoms & disease severity
📌Symptom nature is a powerful predictor of the placebo-controlled efficacy of #PCI
📌Rose angina & typical angina are excellent predictors of the placebo-controlled efficacy of PCI
📌Other symptoms such as SOB are poor predictors of the placebo-controlled efficacy of PCI
Florentina Simader retweeted
#ICYMI @aayshacader asked @rallamee & @FloSimader to summarize the symptom-stratified analysis of ORBITA-2 presented at #EuroPCR!
Florentina Simader retweeted
The symptom stratified analysis of ORBITA2 and the ORBITA-STAR trial both presented at #EuroPCR2024 and simultaneously published in @JACCJournals by @FloSimader and @rajkumar_chris. PCI isn’t a therapy for all symptoms, it’s a therapy for angina @rallamee @mshunshin
Florentina Simader retweeted
🔥 Important new insights from ORBITA-2 study presented today at #EuroPCR
👉🏼 More angina symptoms do not necessarily reflect more extended coronary disease
👉🏼 The clinical history is a strong predictor of the efficacy of PCI
🚨Interroge your patients!
@PCRonline @rallamee
Florentina Simader retweeted
#EuroPCR #JACC LBCT SimPub: #ORBITA-2 symptom-stratified analysis - Although symptom severity & nature were poorly associated with disease severity, the nature of symptoms powerfully predicted the placebo-controlled efficacy of #PCI. bit.ly/3QK76cj
@FloSimader @rallamee
Florentina Simader retweeted
…and this:
O R B I T A 2:
symptom-stratified analysis
⏰ 15/05 8:30
📍 Theatre Havane
👋 Florentina Simader
@rallamee
#EuroPCR 2024
#CoronaryPhysiology
#BypassSurgery
#PercutaneousCoronaryIntervention
#LateBreakingScience
Looking forward to this:
🔥 F A M E 3 analysis:
C A B G vs PCI
C O S T - effectivenes 💰💰💰
👋 Frederik Zimmermann
@wfearonmd
⏰ 08:30 May 15
📍 Theatre Havane
Florentina Simader retweeted
We Are Chasing Impact, Not Impact Factor—my video w/my vision for #JACC. I was frustrated with the peer-reviewed journal establishment, and now I am part of it. So…can we create author-centricity, and high-value for society. @JACCJournals youtube.com/watch?v=bbHSR6gS…
Florentina Simader retweeted
Q: Does blinding matter in RCTs of surgical procedures? A: Depends on the endpoint @JAMASurgery
We compared placebo-controlled and open-label surgical trials to identify when the placebo effect is most powerful @rallamee @KatieEljadi @ImperialNHLI
jamanetwork.com/journals/jam…
Florentina Simader retweeted
Delighted to bring our EAPCI Journal club to 🇬🇧
Discussing #ORBITA2 and the fantastic work by the team:
@rallamee @rajkumar_chris @MikeFoley89 @fiyyazAJ @FloSimader @ProfDFrancis
🚨#EAPCIJournalClub is coming🚨
🎯Discussed trial:
➡️ORBITA-2 (bit.ly/NEJM-Orbita2)
🗓️23 April
⏰18:00 CEST
With:
Dr. Lena Seegers
@rallamee
@ICigalini
@KardiologieHH
‼️Register here‼️
🔗esc365.escardio.org/event/16…
#ByTheFellows #ForTheFellows
Florentina Simader retweeted
Goodbye #ACC from the ORBITA team. Thank you for featuring our work and see you again next year! @FloSimader @ShaynaChotai @MikeFoley89 @rajkumar_chris @fiyyazAJ @mshunshin
